A Python-Derived Molecule Called pTOS Could Point to New Weight-Loss Pathways 

SDRC Investigator Dr. Jonathan Long's latest research reveals how pTOS — a metabolite that surges dramatically in snake blood after a meal — may offer a novel approach to appetite regulation with implications for diabetes care.

Previous
Previous

Why Ozempic May Not Work for Everyone: SDRC Investigator Anna Gloyn and Colleagues Uncover a Genetic Resistance to GLP-1 Drugs

Next
Next

SDRC members highlighted in the new "Walk with Me" video series